AIM ImmunoTech Inc
F:HXB2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AIM ImmunoTech Inc
F:HXB2
|
US |
|
S
|
Sage Group PLC
DUS:SGK1
|
UK |
|
Temenos AG
F:TE8N
|
CH |
|
AMP Ltd
ASX:AMP
|
AU |
|
Lifecare AS
F:LFC
|
NO |
Shareholder Yield
Current shareholder yield for HXB2 is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
HXB2 Price
AIM ImmunoTech Inc
| Average Annual Return | -23.3% |
| Standard Deviation of Annual Returns | 61.11% |
| Max Drawdown | -100% |
| Market Capitalization | 1.9m EUR |
| Shares Outstanding | 57 140 000 |
| Percentage of Shares Shorted |
N/A
|
HXB2 Return Decomposition
Main factors of price return
Stock Splits
HXB2's latest stock split occurred on Jun 12, 2025
The company executed a 1-for-100 stock split, meaning that for every 100 shares held, investors received 1 new share.
The adjusted shares began trading on Jun 12, 2025. This was stock split number 3 in HXB2's history, following the previous one in Jun 11, 2019.
